News
PLRZ
11.48
+0.53%
0.06
Weekly Report: what happened at PLRZ last week (0615-0619)?
Weekly Report · 5d ago
Top Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch
NASDAQ · 06/18 03:15
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery Patent
TipRanks · 06/17 20:28
Polyrizon gets patent for Trap & Target mucoadhesive polymer technology platform
TipRanks · 06/17 13:22
Polyrizon says U.S. publishes patent application for Trap & Target nasal drug delivery platform
PUBT · 06/17 12:15
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
Barchart · 06/17 07:15
Polyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway
TipRanks · 06/15 20:29
POLYRIZON - AGREES WITH EUROPEAN MEDICAL CENTER AND CRO FOR NASARIX HUMAN STUDY
Reuters · 06/15 12:11
Polyrizon Launches Human Study With Top European Medical Center To Validate NASARIX Allergy Blocker's Nasal Residence Time
Benzinga · 06/15 12:10
Polyrizon signs contracts with European medical center, CRO for NASARIX nasal residence-time study
PUBT · 06/15 12:06
Weekly Report: what happened at PLRZ last week (0608-0612)?
Weekly Report · 06/15 10:01
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
Barchart · 06/15 07:05
Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform
TipRanks · 06/10 20:29
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 06/10 12:05
Polyrizon receives notice of European patent publication
TipRanks · 06/10 11:50
Polyrizon Announces European Patent Office To Publish The Company's Application 'Mucoadhesive Polymers For Nasal Drug Delivery'
Benzinga · 06/10 11:50
POLYRIZON RECEIVES NOTICE OF EUROPEAN PATENT PUBLICATION FOR INNOVATIVE MUCOADHESIVE NASAL DRUG DELIVERY TECHNOLOGY
Reuters · 06/10 11:47
Polyrizon says European patent application for mucoadhesive nasal drug delivery technology is published
PUBT · 06/10 11:47
Polyrizon Secures Three Key U.S. Sites for NASARIX Allergy Trial
TipRanks · 06/08 20:29
Polyrizon Sets July 13, 2026 AGM to Vote on Board, Pay and Auditor Mandates
TipRanks · 06/08 20:29
More
Webull provides a variety of real-time PLRZ stock news. You can receive the latest news about Polyrizon Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PLRZ
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..